Drug Patents owned by Pharmacosmos As
1. Drug name - MONOFERRIC
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US10414831 | PHARMACOSMOS AS | Stable iron oligosaccharide compound |
Mar, 2029
(6 years from now) | |
| US8815301 | PHARMACOSMOS AS | Stable iron oligosaccharide compound |
Aug, 2029
(6 years from now) | |
| IN291100B | PHARMACOSMOS AS | A Stable Iron Oligosaccharide Compound |
Mar, 2029
(6 years from now) | |
| IN201108145P1 | PHARMACOSMOS AS | A Stable Iron Oligosaccharide Compound |
Mar, 2029
(6 years from now) | |
| EP2411053B1 | PHARMACOSMOS AS | A Stable Iron Oligosaccharide Compound |
Mar, 2029
(6 years from now) | |
| EP3156075A1 | PHARMACOSMOS AS | An Oligosaccharide And A Process For Preparation Thereof |
Mar, 2029
(6 years from now) | |
| EP3156075B1 | PHARMACOSMOS AS | An Oligosaccharide And A Process For Preparation Thereof |
Mar, 2029
(6 years from now) | |
| EP2411053A1 | PHARMACOSMOS AS | A Stable Iron Oligosaccharide Compound |
Mar, 2029
(6 years from now) | |
Drugs and Companies using FERRIC DERISOMALTOSE ingredient
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1GM/10ML (100MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
| 100MG/ML (100MG/ML) | SOLUTION;INTRAVENOUS | Discontinued |
| 500MG/5ML (100MG/ML) | SOLUTION;INTRAVENOUS | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.